👑 Total Health Panel — Executive

What this panel can settle, and by what logic

At this size the panel is not answering a question — it is building a reference point. Three things it genuinely settles.

1. It settles what your normal looks like, which is the only durable value of a panel this wide. A future result is read against your own previous one, and most markers have a within-person range far narrower than the population interval they are printed against Lorde 2023. The comparison you make in a year is what you are paying for now.
2. It settles the four numbers that actually change management. ApoB (Apolipoprotein B) is a better marker of atherogenic particle burden than LDL-cholesterol or particle number in large cohort data Epstein 2025; HbA1c (Hemoglobin A1c) and Fasting Insulin set the metabolic trajectory; hs-CRP (High-Sensitivity C-Reactive Protein) arbitrates the rest. Everything else on the list is context for those.
3. It settles the once-in-a-lifetime tests in one visit. Lp(a) is around 90% genetically determined and needs measuring once Nurmohamed 2023, and the genetic add-ons never need repeating at all. On a panel this expensive, the tests you will never buy again are the best value in it.

What it cannot settle, and what would

It cannot avoid telling you something is wrong when nothing is. A reference interval is built to contain the central 95% of a healthy population, so each independent marker has about a 1 in 20 chance of falling outside it in a perfectly well person. Across 20 independent markers the chance of at least one flag is about 64%; across 50 it is 92%; across 80 it is over 98%. Real markers are correlated, so the true figure is lower than that — but it is not low, and broadening what counts as abnormal is a recognized driver of overdiagnosis Bandovas 2022. Expect several out-of-range results. They are the product working as specified.

It cannot see the coronary arteries. No number here tells you whether you have plaque. A coronary artery calcium score does, and it adds information beyond risk factors and even beyond a polygenic score Khan 2023. If this panel is being bought as a cardiac check, the $100 CT is the better half of the purchase.

It is not cancer screening. Tumor markers on a broad panel generate far more false alarms than early diagnoses in asymptomatic people; colonoscopy, mammography, low-dose CT and cervical screening are the tests that find cancer early.

And it cannot interpret itself. Hormone immunoassays produce spurious results through interference often enough that an isolated implausible value should be repeated by a different method before it is believed Braunstein 2022 Haddad 2019.

Draw conditions that decide whether the money is wasted

One draw, this many assays, and four preparation rules that protect different parts of it.

1. Fast 9 to 12 hours and go early. The panel contains cortisol, testosterone and insulin, all of which are only interpretable against a morning fasted reference Haddad 2019.
2. 72 hours off biotin, and check every supplement, not just the one labeled biotin. It sits inside hair, nail, energy and multivitamin products, and it distorts streptavidin-based immunoassays across the thyroid and hormone sections at once Braunstein 2022.
3. Leave 48 to 72 hours after hard training. Exercise moves CRP, ferritin, creatine kinase, cortisol and liver enzymes together, which on a panel this size produces a page of flags with one cause.
4. Use the same laboratory every time you repeat it. Between-assay differences are large enough to create an apparent change where none exists Lorde 2023, and the entire value of this purchase is the comparison.

How you would know it answered your question, and what each pattern means next

A protocol for reading it, which matters more here than any single branch.

• Rank before you react. Act on ApoB (Apolipoprotein B), HbA1c (Hemoglobin A1c), Fasting Insulin and hs-CRP (High-Sensitivity C-Reactive Protein) first, then on anything abnormal that has a symptom attached, then on nothing else Epstein 2025.
• Repeat a single borderline result before acting on it. Repeat at 6 to 8 weeks with the same assay: many isolated flags on a panel this wide are analytical or biological variation and resolve on the second draw Lorde 2023.
• An implausible hormone value gets a different method, not a treatment. Ask for mass spectrometry or a repeat after polyethylene-glycol precipitation before accepting a result that does not match you Braunstein 2022.
• HbA1c (Hemoglobin A1c) between 5.7% and 6.4%: recheck at 3 months, and read it beside Ferritin, because iron status shifts HbA1c independently of glucose Chen 2022.
• Everything normal: the correct next purchase is not another panel. Repeat the same panel in 12 months for the comparison, and spend the intervening money on a calcium score if you are over 40 Khan 2023.

Sources read for these sections

• Lorde N, et al. Impact of Variation between Assays and Reference Intervals in the Diagnosis of Endocrine Disorders. Diagnostics (Basel) 2023 · PMID 37998589
• Bandovas JP, et al. Broadening risk factor or disease definition as a driver for overdiagnosis: A narrative review. Journal of Internal Medicine 2022 · PMID 35253285
• Haddad RA, et al. Interpretation of common endocrine laboratory tests: technical pitfalls, their mechanisms and practical considerations. Clinical Diabetes and Endocrinology 2019 · PMID 31367466
• Epstein E, et al. Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK Biobank. European Journal of Preventive Cardiology 2025 · PMID 40887080
• Chen Z, et al. Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review). Experimental and Therapeutic Medicine 2022 · PMID 36382101
• Khan SS, et al. Coronary Artery Calcium Score and Polygenic Risk Score for the Prediction of Coronary Heart Disease Events. JAMA 2023 · PMID 37219552
• Nurmohamed NS, et al. Considerations for routinely testing for high lipoprotein(a). Current Opinion in Lipidology 2023 · PMID 35942815
• Braunstein GD. Spurious Serum Hormone Immunoassay Results: Causes, Recognition, Management. touchREVIEWS in Endocrinology 2022 · PMID 36694886